{"id":"NCT02497001","sponsor":"Pearl Therapeutics, Inc.","briefTitle":"A Randomized, Double-Blind, Parallel-Group, 24-Week, Chronic-Dosing, Multi-Center Study to Assess the Efficacy and Safety of PT010, PT003, and PT009 Compared With Symbicort® Turbuhaler® (Kronos)","officialTitle":"A Randomized, Double-Blind, Parallel-Group, 24-Week, Chronic-Dosing, Multi-Center Study to Assess the Efficacy and Safety of PT010, PT003, and PT009 Compared With Symbicort® Turbuhaler® as an Active Control in Subjects With Moderate to Very Severe Chronic Obstructive Pulmonary Disease","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-08-10","primaryCompletion":"2018-01-05","completion":"2018-01-05","firstPosted":"2015-07-14","resultsPosted":"2020-12-24","lastUpdate":"2020-12-24"},"enrollment":1902,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["COPD"],"interventions":[{"type":"DRUG","name":"BGF MDI 320/14.4/9.6 μg","otherNames":["BGF"]},{"type":"DRUG","name":"GFF MDI (PT003) 14.4/9.6 μg","otherNames":["GFF"]},{"type":"DRUG","name":"BFF MDI (PT009) 320/9.6 μg","otherNames":["BFF"]},{"type":"DRUG","name":"Symbicort® Turbuhaler® (TBH) Inhalation Powder","otherNames":[]}],"arms":[{"label":"BGF MDI (PT010) 320/14.4/9.6 μg ex-actuator","type":"EXPERIMENTAL"},{"label":"GFF MDI (PT003) 14.4/9.6 μg ex-actuator","type":"EXPERIMENTAL"},{"label":"BFF MDI (PT009) 320/9.6 μg ex-actuator","type":"EXPERIMENTAL"},{"label":"Symbicort","type":"ACTIVE_COMPARATOR"}],"summary":"Study to Assess the Efficacy and Safety of PT010, PT003, and PT009 Compared With Symbicort® Turbuhaler® in Subjects with Moderate to Very Severe Chronic Obstructive Pulmonary Disease.","primaryOutcome":{"measure":"FEV1 AUC0-4","timeFrame":"at Week 24","effectByArm":[{"arm":"BGF MDI 320/14.4/9.6 μg","deltaMin":0.292,"sd":null},{"arm":"GFF MDI (PT003) 14.4/9.6 μg","deltaMin":0.288,"sd":null},{"arm":"BFF MDI (PT009) 320/9.6 μg","deltaMin":0.177,"sd":null},{"arm":"Symbicort®","deltaMin":0.189,"sd":null}],"pValues":[]},"eligibility":{"minAge":"40 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":7,"exclusionCount":8},"locations":{"siteCount":190,"countries":["United States","Canada","China","Japan"]},"refs":{"pmids":["40340809","39691156","39103901","35815359","35478081","34182998","33152467","32152869","31920296","31841699","30232048"],"seeAlso":["http://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_7111&studyid=4148&filename=PT010006-02_FINAL_Redacted_17MAY2018.pdf","https://filehosting-v2.pharmacm.com/api/Attachment/Download?tenantId=80217111&amp;parentIdentifier=PT010006&amp;attachmentIdentifier=e464d4a5-e38a-47b1-8e03-b8acd1cbd842&amp;fileName=PT010006_SAP_v2.0_Redacted_PDFA.pdf&amp;versionIdentifier="]},"adverseEventsSummary":{"seriousAny":{"events":55,"n":639},"commonTop":["Nasopharyngitits","Upper Respiratory Infection","Muscle Spasms"]}}